PP-041 Extemporaneous preparation of oral liquid formulation of capecitabina by Romero, R Morón, Corpas, M Valle, Medina, MDC González, Peña, C Gómez, Romero, A Caballero, Guardia, A Valle Ruiz de la, Delgado, A Rodriguez, Barrera, J Cabeza

Get full text

CP-191 Impact of medication reconciliation at hospital admission in surgical patients by Peña, C Gómez, Fernández, C García, Medina, MDC González, Corpas, M Valle, Romero, R Morón, Hidalgo, I Casas, Barrera, J Cabeza

Get full text

CP-200 Reactivation of hepatitis B after antineoplastic or immunosuppressive therapy by Fernández, C García, Peña, C Gómez, Romero, R Morón, Hidalgo, I Casas, Medina, MDC González, Corpás, M Valle, Rustarazo, S Belda, Fuentes, S Ruíz

Get full text

CP-069 Evaluation of the effectiveness of fampridine and comparison with a clinical trial by Díaz-Villamarín, X, Fajardo, CL Dávila, Romero, R Morón, Medina, MDC González, Corpas, M Valle, Hidalgo, I Casas, Fernández, C García, Gómez-Peña, C, Cabeza-Barrera, J, Marín, C

Get full text

PKP-023 Interleukin 6 G >G genetic polymorphism (RS1800795) and the response to tocilizumab in rheumatoid arthritis patients by González-Medina, MDC, Díaz-Villamarín, X, Dávila-Fajardo, CL, Soto-Pino, MJ, Gómez-Martín, A, Martínez-González, LJ, Casas-Hidalgo, I, Sánchez-Yáñez, E, Domínguez-Cantero, M, Cabeza-Barrera, J

Get full text

PKP-024 The FCGR2A (A >G) (RS1801274) genetic variant and the efficacy of tocilizumab in rheumatoid arthritis patients by González-Medina, MDC, Dávila-Fajardo, CL, Soto-Pino, MJ, Díaz-Villamarín, X, Gómez-Martín, A, Martínez-González, LJ, Núñez, M, Casas-Hidalgo, I, Cabeza-Barrera, J

Get full text

OHP-026 Prophylactic treatment of chronic migraine with botulinum toxin: study population by Fernández, C García, Peña, C Gómez, Rustarazo, S Belda, Delgado, A Rodriguez, Hidalgo, I Casas, Medina, MDC Gonzalez, Gómez, P Nieto

Get full text

CP-009 Risk assessment of diabetes ketoacidosis in type 2 diabetes mellitus patients treated with sodium–glucose cotransporter type 2 inhibitors by Martinez, D Blanquez, Ponce, M Hayon, Romero, A Caballero, Villamarin, X Diaz, Medina, MDC Gonzalez, Hidalgo, I Casas, Delgado, A Rodriguez, Raya, P Moreno

Get full text

DI-055 Evaluation of tocilizumab response in rheumatoid arthritis. Comparision of the results with the clinical trial by Medina, MDC Gonzalez, Fajardo, C Davila, Villamarin, X Diaz, Pino, MJ Soto, Martinez, LJ, Martinez, D Blanquez, Corpas, M Valle, Alvarez, E Raya, Romero, R Moron, Barrera, J Cabeza

Get full text

PKP-022 The KCNMB1 (A >G) (RS703505) genetic variant and the efficacy of tocilizumab in rheumatoid arthritis patients by Díaz-Villamarín, X, Dávila-Fajardo, CL, Gónzalez-Medina, MDC, Soto-Pino, MJ, Sánche-Gómez, E, Acuña, A, Gómez-Martín, A, Martínez-González, LJ, Casas-Hidalgo, I, Cabeza-Barrera, J

Get full text

PP-026 The importance of auditing parenteral nutrition compounding process by Medina, A Liras, Moreno-García, M, Martínez-Núñez, ME, Vázquez-Sánchez, R, Salas, R Montes, Cerro-González, MDC Del, Molina-García, T

Get full text

The influence of fear avoidance beliefs on disability and quality of life is sparse in Spanish low back pain patients by Kovacs, Francisco M, Muriel, Alfonso, Abriaira, Victor, Medina, Jose Maria, Castillo Sanchez, Maria Dolores, Olabe, Javier

Get full text